Discovery of a Potent, Selective, and Orally Bioavailable c-Met Inhibitor: 1-(2-Hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458)
Work
Year: 2008
Type: article
Source: Journal of Medicinal Chemistry
Institution Amgen (United States)
Cites:
Cited by: 92
Related to: 10
FWCI: 2.885
Citation percentile (by year/subfield): 99.98
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed